Retracted: Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with Type 2 diabetes-Reference-Cited by-同舟云学术

Retracted: Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with Type 2 diabetes

Published:2014-06-19 Issue:12 Volume:31 Page:1515-1523
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Derosa G.¹²,Bonaventura A.¹,Bianchi L.¹,Romano D.¹,Fogari E.¹,D'Angelo A.¹,Maffioli P.¹

Affiliation:

1. Department of Internal Medicine and Therapeutics; University of Pavia and; Fondazione IRCCS Policlinico S. Matteo

2. Centre for the Study of Endocrine-Metabolic Pathophysiology and Clinical Research; University of Pavia; Pavia Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.12499/fullpdf

Reference35 articles.

1. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

2. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes;Kahn;Diabetologia,2003

3. Alpha cell function in health and disease: influence of glucagon-like peptide-1;Dunning;Diabetologia,2005

4. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes;Butler;Diabetes,2003

5. Global guideline for type 2 diabetes: recommendations for standard, comprehensive, and minimal care;IDF Clinical guidelines Task Force;Diabet Med,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis;Diabetes, Metabolic Syndrome and Obesity;2024-06

2. Comparative clinical study evaluating the effect of adding Vildagliptin versus Glimepiride to ongoing Metformin therapy on diabetic patients with symptomatic coronary artery disease;Diabetes Research and Clinical Practice;2020-12

3. Effect of dipeptidyl-peptidase-4 inhibitors on C-reactive protein in patients with type 2 diabetes: a systematic review and meta-analysis;Lipids in Health and Disease;2019-06-18

4. Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study;British Journal of Clinical Pharmacology;2019-04-13

5. Impact of dipeptidyl-peptidase 4 inhibitors on cardiovascular diseases;Vascular Pharmacology;2018-10